Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. QCOM
2. FDX
3. CBRS
4. USO
5. MU
6. SPY
7. KBH
8. HON
9. HTZ
10. GOOGL

Go back to Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Aviragen Therapeutics (AVIR) Misses Q4 EPS by 5c

March 6, 2025 4:11 PM EST

Aviragen Therapeutics (NASDAQ: AVIR) reported Q4 EPS of ($0.40), $0.05 worse than the analyst estimate of ($0.35).

For earnings history and earnings-related data on Aviragen Therapeutics (AVIR) click here.

... More